Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikael Hoffmann

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Scandinavian Journal of Pain|July 27, 2021
Opioid availability statistics from the International Narcotics Control Board do not reflect the medical use of opioids: comparison with sales data from ScandinaviaEmmanuel Bäckryd, Markus Heilig, Mikael Hoffmann
Lakartidningen|June 20, 2008
[How is the renewing of prescriptions handled in clinical practice?]J Lars G Nilsson, Mikael Hoffmann
Lakartidningen|May 10, 2017
[Opioid prescription changes in Sweden 2000–2015]Emmanuel Bäckryd, Markus Heilig, Mikael Hoffmann
Lakartidningen|April 18, 2024
Mikael Hoffmann, Magnus Isacson, Rikard Lövström
Studies in Health Technology and Informatics|May 19, 2023
Challenges with Medication Management and the National Medication List in Sweden: An Interview Study from a Human, Organizational, and Technology PerspectiveTora Hammar, Mikael Hoffmann, Lina Nilsson
Basic & Clinical Pharmacology & Toxicology|April 27, 2016
The First Decade with the Swedish Prescribed Drug Register - A Systematic Review of the Output in the Scientific LiteratureSusanna M Wallerstedt, Björn Wettermark, Mikael Hoffmann
Lakartidningen|February 21, 2015
[Clinical decision support can provide assistance in complex health care]Rikard Lövström, Mikael Hoffmann, Lars L Gustafsson
British Journal of Clinical Pharmacology|July 30, 2021
Methodological issues in research on drug-related admissions: A meta-epidemiological review with focus on causality assessmentsSusanna M Wallerstedt, Mikael Hoffmann, Johan Lönnbro
Ugeskrift for Laeger|February 13, 2009
[GPs' perceptions of the Institute for Rational Pharmacotherapy]Claire Gudex, Mikael Hoffmann, Odd Brørs, et al.
Health Policy (Amsterdam, Netherlands)|November 26, 2011
Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in SwedenBillie Pettersson, Mikael Hoffmann, Per Wändell, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Scandinavian Journal of Pain|July 27, 2021
Opioid availability statistics from the International Narcotics Control Board do not reflect the medical use of opioids: comparison with sales data from ScandinaviaEmmanuel Bäckryd, Markus Heilig, Mikael Hoffmann
Lakartidningen|June 20, 2008
[How is the renewing of prescriptions handled in clinical practice?]J Lars G Nilsson, Mikael Hoffmann
Lakartidningen|May 10, 2017
[Opioid prescription changes in Sweden 2000–2015]Emmanuel Bäckryd, Markus Heilig, Mikael Hoffmann
Lakartidningen|April 18, 2024
Mikael Hoffmann, Magnus Isacson, Rikard Lövström
Studies in Health Technology and Informatics|May 19, 2023
Challenges with Medication Management and the National Medication List in Sweden: An Interview Study from a Human, Organizational, and Technology PerspectiveTora Hammar, Mikael Hoffmann, Lina Nilsson
Basic & Clinical Pharmacology & Toxicology|April 27, 2016
The First Decade with the Swedish Prescribed Drug Register - A Systematic Review of the Output in the Scientific LiteratureSusanna M Wallerstedt, Björn Wettermark, Mikael Hoffmann
Lakartidningen|February 21, 2015
[Clinical decision support can provide assistance in complex health care]Rikard Lövström, Mikael Hoffmann, Lars L Gustafsson
British Journal of Clinical Pharmacology|July 30, 2021
Methodological issues in research on drug-related admissions: A meta-epidemiological review with focus on causality assessmentsSusanna M Wallerstedt, Mikael Hoffmann, Johan Lönnbro
Ugeskrift for Laeger|February 13, 2009
[GPs' perceptions of the Institute for Rational Pharmacotherapy]Claire Gudex, Mikael Hoffmann, Odd Brørs, et al.
Health Policy (Amsterdam, Netherlands)|November 26, 2011
Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in SwedenBillie Pettersson, Mikael Hoffmann, Per Wändell, et al.
Pageof 7